From: Analysis of selected polymorphisms in FOXP3 gene in a cohort of Egyptian patients with schizophrenia
Age years (mean ± SD) | 32.45 ± 9.167 |
Gender: male/female | 54/71 |
Duration of illness: years (mean ± SD) | 9.48 ± 6.875 |
Family history: no/yes | 78/47 |
Smoking: no/yes | 49/76 |
Marital status: single/married/divorced | 71/34/20 |
Antipsychotic medication: no/yes | 22/103 |
Mood stabilizer: no/yes | 93/32 |
Antidepressant: no/yes | 77/48 |
Diabetes/hypertension: no/yes | 117/8 |
Positive scale 7–49 (mean ± SD) | 16.66 ± 4.675 |
Negative scale 7–49 (mean ± SD) | 19.30 ± 15.939 |
General psychopathology 16–112 (mean ± SD) | 55.54 ± 27.286 |
Total score | 91.48 ± 30.815 |
HB g/dl (mean ± SD) | 15.362 ± 15.546 |
Wbcs 109/l (mean ± SD) | 7.215 ± 1.824 |
Platelets 109/l (mean ± SD) | 228.79 ± 87.216 |
ALT U/l (mean ± SD) | 25.47 ± 14.229 |
Glucose mg/dl (mean ± SD) | 93.98 ± 19.122 |
Creatinine mg/dl (mean ± SD) | 0.980 ± 0.4879 |
Cholesterol mg/dl (mean ± SD) | 190.55 ± 133.152 |